☆ 4.6 Article

Synthesis, antimycobacterial evaluation, and molecular docking study of 1,2,4-triazole derivatives

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

Antimycobacterial Compound of Cynoglossum lanceolatum Forsk.: Bioassay Guided Isolation, Molecular Docking, Synthesis of Analogs, and a Plausible Mechanism of Action

Xin Zhao et al.

Summary: Tuberculosis (TB) is a major health threat due to drug-resistant strains of Mycobacterium tuberculosis (Mtb). This study investigated the effectiveness of the Traditional Chinese Medicine Cynoglossum lanceolatum Forsk in treating TB. The active component, shikonin, was isolated and found to have an MIC of 128 μg/mL against Mtb. A derivative of shikonin, (E)-1-(6-bromo-2,3-dihydrochromen-4-ylidene)thiosemicarbazide, was synthesized with a stronger activity (MIC=4 μg/mL). Both compounds were found to inhibit the catalytic activity of Mtb KatG and cause ROS accumulation in Mtb cells, suggesting a novel mechanism of action.

CHEMISTRY & BIODIVERSITY (2023)

添加到收藏夹

Article Chemistry, Applied

Antituberculosis, antioxidant and cytotoxicity profiles of quercetin: a systematic and cost-effective in silico and in vitro approach

Shasank S. Swain et al.

Summary: The study selected seven plant-derived polyphenols and verified their anti-TB and drug-ability profiles using advanced computational tools before experimental study. Quercetin showed promising potential as an anti-TB drug candidate, with good docking score and drug-ability score.

NATURAL PRODUCT RESEARCH (2022)

添加到收藏夹

Article Infectious Diseases

The WHO Global Tuberculosis 2021 Report - not so good news and turning the tide back to End TB

Jeremiah Chakaya et al.

Summary: The 2021 WHO global TB report presents a grim situation in the global epidemic of TB, including a stagnation in TB incidence decline, a decline in TB notifications, and an increase in estimated TB deaths. None of the targets set at the 2018 United Nations High Level Meeting on TB were achieved. The sub-optimal global performance in achieving TB control targets in 2020 is attributed to the COVID-19 pandemic, but TB programs were already off track before the pandemic, highlighting the fragility of the global TB response. Ending the global TB epidemic requires bold leadership, optimization of interventions, widespread coverage, addressing social determinants, and mobilization of adequate funding.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Immunology

Quinoline derivatives as potential anti-tubercular agents: Synthesis, molecular docking and mechanism of action

Chun-Xiu Liu et al.

Summary: This study synthesized a series of compounds and found that compound 5 could be an inhibitor of KatG in Mycobacterium tuberculosis. The findings suggest that KatG could be a potential new target for designing new anti-tubercular drugs.

MICROBIAL PATHOGENESIS (2022)

添加到收藏夹

Article Microbiology

In Vitro Profiling of Antitubercular Compounds by Rapid, Efficient, and Nondestructive Assays Using Autoluminescent Mycobacterium tuberculosis

Gauri S. Shetye et al.

Summary: The optimization of autoluminescent Mycobacterium tuberculosis-based in vitro assays in this study provides rapid and dynamic biological information for anti-TB drug discovery. These assays streamline the profiling process and reduce the time required for comprehensive in vitro testing by two months, allowing for efficient evaluation of TB drug leads. The time- and concentration-dependent kill information obtained from luminescence-based assays can be used for pharmacokinetic-pharmacodynamic modeling and revealed differences in bactericidal activity between tested compounds.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against Mycobacterium tuberculosis

Pran Kishore Deb et al.

Summary: A series of 3,5-disubstituted-1,2,4-oxadiazole derivatives showed promising activity against multi- and extensively drug-resistant strains of Mycobacterium tuberculosis, with compound 3a demonstrating the best efficacy. Molecular docking studies identified polyketide synthase (Pks13) enzyme as the putative target, making these compounds, particularly compound 3a, worthy of further optimization.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

The burdens of tuberculosis on patients with malignancy: incidence, mortality and relapse

Chin-Chung Shu et al.

SCIENTIFIC REPORTS (2019)

添加到收藏夹

Review Chemistry, Medicinal

Triazole derivatives and their anti-tubercular activity

Shu Zhang et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Anti-tubercular Activity of Pyrazinamide is Independent of trans-Translation and RpsA

Nicholas A. Dillon et al.

SCIENTIFIC REPORTS (2017)

添加到收藏夹

Article Microbiology

Acid-Fast Positive and Acid-Fast Negative Mycobacterium tuberculosis: The Koch Paradox

Catherine Vilcheze et al.

MICROBIOLOGY SPECTRUM (2017)

添加到收藏夹

Letter Medicine, General & Internal

Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis

Guido V. Bloemberg et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

添加到收藏夹

Article Medicine, Research & Experimental

Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm

Sumit Chakraborty et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)

添加到收藏夹

Article Chemistry, Multidisciplinary

Cytotoxic effects of etephon and maleic hydrazide in Vero, Hep2, HepG2 cells

Begum Yurdakok et al.

DRUG AND CHEMICAL TOXICOLOGY (2014)

添加到收藏夹

Article Biochemistry & Molecular Biology

Manganese(II) complexes with thiosemicarbazones as potential anti-Mycobacterium tuberculosis agents

Carolina G. Oliveira et al.

JOURNAL OF INORGANIC BIOCHEMISTRY (2014)

添加到收藏夹

Article Microbiology

Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities

Catherine Vilcheze et al.

MICROBIOLOGY SPECTRUM (2014)

添加到收藏夹

Article Chemistry, Medicinal

Identification of Compounds with Potential Antibacterial Activity against Mycobacterium through Structure-Based Drug Screening

Tomohiro Kinjo et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS production

Mark P. Brynildsen et al.

NATURE BIOTECHNOLOGY (2013)

添加到收藏夹

Article Immunology

A simple in vitro PK/PD model system to determine time-kill curves of drugs against Mycobacteria

Nageshwar R. Budha et al.

TUBERCULOSIS (2009)

添加到收藏夹

Article Biochemistry & Molecular Biology

A common mechanism of cellular death induced by bactericidal antibiotics

Michael A. Kohanski et al.

CELL (2007)

添加到收藏夹

Article Biochemistry & Molecular Biology

Modification of the active site of Mycobacterium tuberculosis KatG after disruption of the Met-Tyr-Trp cross-linked adduct

Sofia M. Kapetanaki et al.

JOURNAL OF INORGANIC BIOCHEMISTRY (2007)

添加到收藏夹

Article Biochemistry & Molecular Biology

Crystal structure of Mycobacterium tuberculosis catalase-peroxidase

T Bertrand et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.